Merck's heart failure drug misses trial goals

Courtesy Newsvine - business  Fri, 06/05/2009 - 07:25

Merck says its heart failure treatment rolofylline missed its goals in a trial, failing to improve patient symptoms compared with a placebo.


 

Related items

Merck loses $473M tax appeal in Schering case
A three-judge federal appeals court panel on Monday rejected an attempt by drugmaker Merck & Co. to win a refund of nearly $500 million in taxes assessed two decades ago.

Selected first-quarter drug sales for Merck & Co.
Here are sales figures for the first quarter for Merck & Co.'s 10 top-selling drugs:

FDA says Merck drug successfully fights hepatitis
Federal health officials say a highly-anticipated drug to treat hepatitis C made by Merck appears to cure more patients in less time than established drugs that have been used for 20 years....

Samsung SCX-4200 3-in-1 True Multifunction Printer
The SCX-4200 Digital Productivity Center is a low cost black and white laser printer, delivering 3 in 1 true multifunction performance with professional laser output.Keep your valuable real...

BlueAnt UNOTPBAX53 X5 Bluetooth Stereo Headphone...
The X5 Stereo Bluetooth Headset is a portable multi-function device utilizing the latest cutting edge technologies allowing you to stream high quality music and make voice calls using a...


 

Post new comment

The content of this field is kept private and will not be shown publicly.
CAPTCHA
We apologize for the inconvenience. Please help fight spam.
business.marc8.com